Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT

v3.5.0.2
STOCKHOLDERS' DEFICIT
6 Months Ended
Jun. 30, 2016
STOCKHOLDERS' DEFICIT  
STOCKHOLDERS' DEFICIT

NOTE 6 - STOCKHOLDERS’ DEFICIT

 

Board of Directors fees

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Philip M. Rice (CFO and a Director) in January, 2015, at an exercise price of $.09 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $3,664 using the Black Scholes pricing model relying on the following assumptions: volatility 128.38%; annual rate of dividends 0%; discount rate 0.68%.  In addition, Mr. Rice will receive $10,000 for each annual term served, paid quarterly

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 50,000 shares of common stock to Thomas K. Cox in June, 2015, at an exercise price of $.15 per share.  The warrants have a term of three years and vested or will vest as follows: 12,500 vested on the grant date and the remaining 37,500 shall vest quarterly (12,500 per quarter).  The warrants were valued at $6,185 using the Black Scholes pricing model relying on the following assumptions: volatility 155.43%; annual rate of dividends 0%; discount rate 1.09%.  In addition, Mr. Cox is entitled to receive $10,000 for each annual term served.

 

On September 10, 2015, the board of directors amended its policy for the compensation of its directors. The Board granted to each of its Directors warrants to purchase 250,000 shares of common stock at an exercise price of $.10 per share. The warrants have a term of five years and vest immediately. The unvested portion of the previously granted warrants were cancelled due to the Company’s change to a program where all director warrant grants are made once per year at the same time. As such, Mr. Rice’s unvested warrant of 15,890 shares and Mr. Cox’s unvested warrant of 36,986 were cancelled.

 

As compensation for serving as a member of the board of directors, the Company granted warrants to purchase 125,000 shares of common stock to Robert O. Rondeau, a new Director, in March 2016, at an exercise price of $.09 per share.  The warrants have a term of five years and vest immediately.  The warrants were valued at $10,588 using the Black Scholes pricing model relying on the following assumptions: volatility 168.01%; annual rate of dividends 0%; discount rate 0.97%.  In addition, Mr. Rondeau will receive $10,000 for each annual term served, paid quarterly.

 

The Company recorded directors’ fees of $30,588 and $29,912 for the six months ended June 30, 2016 and 2015, respectively, representing the fees expensed and the value of the vested warrants described above.

 

Stock Based Compensation

 

During the six months ended June 30, 2016, the Company issued warrants to purchase 14,500,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to agreements with financial consultants.  The warrants were valued at $1,095,063 using the Black Scholes pricing model relying on the following assumptions: volatility 170.07%; annual rate of dividends 0%; discount rate 0.89%.  

 

During the six months ended June 30, 2015, the Company issued 500,000 shares of common stock to an investor relations consulting firm.  The shares were valued at $30,000.  The Company also issued warrants to purchase 3,125,000 shares of common stock at an exercise price of $.08 with a term of 5 years pursuant to an agreement with a financial consultant.  The warrants were valued at $285,305 using the Black Scholes pricing model relying on the following assumptions: volatility 143.36% to 150.93%; annual rate of dividends 0%; discount rate 0.15% to 1.75%.  

 

Stock Issuances

 

During the six months ended June 30, 2015, the Company received proceeds of $48,500 from the issuance of 970,000 shares of common stock.  The Company also issued 384,300 shares of common stock valued at $38,300 and warrants to purchase 1,067,500 shares of common stock at an exercise price of $.10 per share as financing cost related to the issuance of the 11% convertible debt. The warrants were valued at $384,111 using the Black Scholes pricing model relying on the following assumptions: volatility 138.6% to 150.9%; annual rate of dividends 0%; discount rate 0.62% to 1.75%.

 

Executive Compensation

 

As compensation for serving as Chief Financial Officer, the Company, quarterly, will issue warrants to Philip M. Rice to purchase 50,000 shares of common stock at the prevailing market price with a term of 5 years, provided that the preceding quarterly and annual filings were submitted in a timely and complaint manner, at which time such warrants would vest.

 

On April 6, 2015 the Company issued warrants to purchase 50,000 shares of common stock at $.085.  The warrants were valued at $3,800 using the Black Scholes pricing model relying on the following assumptions: volatility 143.17%; annual rate of dividends 0%; discount rate 1.31%.  On May 13, 2015, the Company issued warrants to purchase 50,000 shares of common stock at $.08.  The warrants were valued at $3,582 using the Black Scholes pricing model relying on the following assumptions: volatility 143.464%; annual rate of dividends 0%; discount rate 1.57%.

 

On March 29, 2016 the Company issued warrants to purchase 50,000 shares of common stock at $.08.  The warrants were valued at $3,771 using the Black Scholes pricing model relying on the following assumptions: volatility 169.28%; annual rate of dividends 0%; discount rate 0.78%.  On May 13, 2016, the Company issued warrants to purchase 50,000 shares of common stock at $.08.  The warrants were valued at $3,777 using the Black Scholes pricing model relying on the following assumptions: volatility 170.23%; annual rate of dividends 0%; discount rate 0.76%.

 

A summary of the status of the Company’s warrants is presented below.

 

 

June 30, 2016

December 31, 2015

 

Number of

Weighted Average

Number of

Weighted Average

 

Warrants

Exercise Price

Warrants

Exercise Price

 

 

 

 

 

Outstanding, beginning of year

14,705,818

$       0.13

9,053,005

$         0.16

Issued

15,975,000

0.08

7,192,500

0.09

Exercised

-

-

-

-

Cancelled

-

-

(96,575)

0.14

Expired

(150,000)

0.21

(1,443,112)

0.13

Outstanding, end of period

30,530,818

$       0.105

14,705,818

$      0.13

 

 

Warrants outstanding and exercisable by price range as of June 30, 2016 were as follows:

 

 

Outstanding Warrants

 

Exercisable Warrants

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Remaining

 

 

 

 

 

Average

 

Range of

 

Number

 

Contractual Life in Years

 

Exercise Price

 

Number

 

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

18,025,000

 

4.52

$

0.08

 

18,025,000

$

0.08

 

0.085

 

50,000

 

3.77

 

0.085

 

50,000

 

0.085

 

0.088

 

50,000

 

3.87

 

0.088

 

50,000

 

0.088

 

0.09

 

209,110

 

3.20

 

0.09

 

209,110

 

0.09

 

0.10

 

4,802,200

 

4.11

 

0.10

 

4,802,200

 

0.10

 

0.12

 

2,635,367

 

1.03

 

0.12

 

2,635,367

 

0.12

 

0.14

 

50,000

 

3.12

 

0.14

 

50,000

 

0.14

 

0.15

 

2,485,274

 

1.80

 

0.15

 

2,485,274

 

0.15

 

0.17

 

50,000

 

2.75

 

0.17

 

50,000

 

0.17

 

0.19

 

100,000

 

1.96

 

0.19

 

100,000

 

0.19

 

0.20

 

250,000

 

0.83

 

0.20

 

250,000

 

0.20

 

0.22

 

477,004

 

0.34

 

0.22

 

477,004

 

0.22

 

0.25

 

707,000

 

2.02

 

0.25

 

707,000

 

0.25

 

0.30

 

250,000

 

2.41

 

0.30

 

250,000

 

0.30

 

0.33

 

250,000

 

2.00

 

0.33

 

250,000

 

0.33

 

0.36

 

39,863

 

0.34

 

0.36

 

39,863

 

0.36

 

0.38

 

100,000

 

0.28

 

0.38

 

100,000

 

0.38

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30,530,818

 

1.42

 

 

 

30,530,818

$

0.105